Refractory, accelerated phase Chronic myeloid leukemia

DrugDrug NameDrug Description
DB04865Omacetaxine mepesuccinateA cephalotaxine used in the treatment of Chronic Myeloid Leukemia (CML) that is intolerant to or resistant to two or more tyrosine kinase inhibitors.
DrugDrug NamePhaseStatusCount